Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Shock”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00776568
What this trial is testing

Treatment of Refractory Angina Pectoris by Shock Wave Therapy

Who this might be right for
Angina Pectoris
Universal Research Group 60
Not applicableUnknownNCT03968926
What this trial is testing

Hypotension During Extracorporeal Circulatory Support Indicated for Cardiogenic Shock

Who this might be right for
Extracorporeal Life SupportHypotensionVasoplegia
University Hospital, Montpellier 150
Early research (Phase 1)Not Yet RecruitingNCT07166549
What this trial is testing

Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

Who this might be right for
B Cell MalignanciesB-cell LeukemiaB Cell Lymphoma+2 more
University Hospital, Basel, Switzerland 12
Not applicableUnknownNCT04031794
What this trial is testing

ECMO for Critically Ill Patients With Respiratory Failure and/or Circulatory Failure

Who this might be right for
Severe Acute Respiratory Distress SyndromeRefractory Hypoxemia
Mahidol University 250
Not applicableLooking for participantsNCT07596446
What this trial is testing

FEMART-1 Pilot Study

Who this might be right for
Sudden Cardiac ArrestOut-of-hospital Cardiac Arrest (OHCA)Cardiogenic Shock Acute
Emergency Medical Service, Prague 60
Not applicableLooking for participantsNCT05788120
What this trial is testing

Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by ECMO-VA for Refractory Cardiogenic Shock

Who this might be right for
Cardiac Rhythm Disorder
Assistance Publique - Hôpitaux de Paris 600
Post-approval studies (Phase 4)Looking for participantsNCT07609940
What this trial is testing

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 30
Large-scale testing (Phase 3)Looking for participantsNCT06351150
What this trial is testing

Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock

Who this might be right for
Vasodilatory Shock
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 214
Testing effectiveness (Phase 2)Study completedNCT04555798
What this trial is testing

Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

Who this might be right for
Patients With Respiratory Failure and Shocked
Mohamed Gaber Allam 100
Not applicableUnknownNCT04970602
What this trial is testing

The Effect of Early Use of Methylene Blue on Hemodynamics in Septic Shock

Who this might be right for
Septic Shock
Xiangya Hospital of Central South University 106
Large-scale testing (Phase 3)Looking for participantsNCT07502118
What this trial is testing

NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)

Who this might be right for
Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL)Relapsed/Refractory Non-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma (DLBCL)+2 more
Health Institutes of Turkey 40
Not applicableLooking for participantsNCT07027202
What this trial is testing

Early Preventive Left Ventricle Unloading After VA-ECMO for Refractory Cardiogenic Shock

Who this might be right for
Cardiogenic Shock Acute
Assistance Publique - Hôpitaux de Paris 298
Early research (Phase 1)Study completedNCT02761915
What this trial is testing

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

Who this might be right for
Relapsed or Refractory Neuroblastoma
Cancer Research UK 17
Not applicableStudy completedNCT04323709
What this trial is testing

Levosimendan for Veno-arterial ECMO Weaning

Who this might be right for
Cardiogenic ShockRefractory Shock
Hospices Civils de Lyon 200
Testing effectiveness (Phase 2)Study completedNCT00676585
What this trial is testing

Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest

Who this might be right for
Cardiac Arrest
Beth Israel Deaconess Medical Center 50
Early research (Phase 1)Active Not RecruitingNCT03696784
What this trial is testing

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

Who this might be right for
LymphomaLymphoma, B-CellImmune System Diseases+2 more
UNC Lineberger Comprehensive Cancer Center 12
Not applicableUnknownNCT03583970
What this trial is testing

Veno-arterial Extracorporeal Membrane Oxygenation Prior to Left Ventricular Assist Device Implantation.

Who this might be right for
Cardiogenic ShockHeart FailureExtracorporeal Membrane Oxygenation+1 more
Central Hospital, Nancy, France 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06306001
What this trial is testing

Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock

Who this might be right for
Neonatal SepsisShock, Septic
Post Graduate Institute of Medical Education and Research, Chandigarh 130
Testing effectiveness (Phase 2)Study completedNCT02008877
What this trial is testing

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors (MPNST)Sarcoma
Sarcoma Alliance for Research through Collaboration 20
Post-approval studies (Phase 4)Enrolling By InvitationNCT07212686
What this trial is testing

Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension

Who this might be right for
Vasodilatory Shock
Todd Sweberg 30
Next Page